2 vials Save $65

Tesamorelin 10mg

Lyophilized research peptide

$199.99

Ipamorelin 10mg

Lyophilized research peptide

$124.99

Research bundle · 2 vials

Tesamorelin 10mg + Ipamorelin 10mg Research Bundle

USA Made, ≥99% Purity Per Compound

Separate retail vials: Tesamorelin 10mg; Ipamorelin 10mg
USA manufactured in a Certified GMP California and Arizona laboratory.
≥99% purity target per compound with independent third-party HPLC, mass spectrometry, and batch-specific COAs

Combined retail value$324.98

Bundle saving−$65.00

$259.98 $324.98 Save $65

Each vial ships in its original retail format with its own batch COA

Dispatched from a US warehouse within 48 hours, tracked

Store at -20°C (Freeze) or 2–8°C (Refrigerated) protected from light

Disclaimer

For research purposes only. Not intended for human consumption, medical use, diagnosis, treatment, or prevention of disease.

Per-compound specifications

2 vials

Nothing in this bundle is co-formulated. Each vial keeps its own identity, purity target, and certificate, and is specified separately below.

Vial 01

Tesamorelin 10mg

Sequence

N-terminal trans-3-hexenoyl-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL

CAS: 218949-48-5
Molecular mass: 5,136 g/mol
Purity target: ≥99%
Form: Lyophilized Powder

Vial 02

Ipamorelin 10mg

Sequence

Aib-His-D-2-Nal-D-Phe-Lys-NH2

CAS: 170851-70-4
Molecular mass: 711.9 g/mol
Purity target: ≥99%
Form: Lyophilized Powder

Form: 2 Separate Lyophilized Powders
Purity target: ≥99% per compound (3rd-Party HPLC Tested)
Origin: All Included Products: Synthesized, Formulated & Packaged in CA/AZ, USA
Storage: Store at -20°C (Freeze) or 2–8°C (Refrigerated) protected from light

What is the Tesamorelin 10mg + Ipamorelin 10mg Research Bundle?

This two-vial research bundle combines Tesamorelin 10mg and Ipamorelin 10mg. Tesamorelin is a modified 44-amino-acid GHRH analog used to study receptor activation and downstream growth-hormone-axis signals. Ipamorelin is a modified five-residue peptide studied as a selective GHS-R1a, or ghrelin-receptor, agonist.

Together, the set supports controlled work across GHRH-receptor and ghrelin-receptor signaling through two separate research materials. Each retail product stays in its own lyophilized vial, so the bundle does not create a new formulation or establish a proven combined effect.

How It Works

Tesamorelin models GHRH-receptor signaling: Receptor engagement supports controlled measurement of cAMP-linked pituitary and downstream pathway markers.

Ipamorelin engages GHS-R1a: This ghrelin-receptor route provides a defined growth-hormone-secretagogue signal in experimental models.

Separate vials protect experimental control: Study either retail product independently or compare their distinct signals without treating the bundle as one formulation.

Analytical data

One certificate per vial

Independent third-party HPLC assesses each compound against its ≥99% purity target, while mass spectrometry confirms identity. For each vial, the results are documented in one combined, batch-specific COA report.

Lot: T522
Reported: 2026-04-23
Identity (LC-MS): Confirmed
Purity (HPLC-UV): 99.58%
Net content: 9.85 mg
Appearance: White lyophilized powder

Download COA

Lot: IP341
Reported: 2026-06-01
Identity (LC-MS): Confirmed
Purity (HPLC-UV): 99.88%
Net content: 10.29 mg
Appearance: White lyophilized powder

Download COA

Why Source from 321 Peptides?

Domestic accountability.

All included compounds are synthesized, manufactured, formulated, finished, and packaged in Certified GMP laboratory facilities in California and Arizona—never sourced from overseas or Mexico. That creates direct domestic supply-chain accountability from production through fulfillment.

Verification you can inspect.

Independent third-party HPLC evaluates each compound against its ≥99% purity target, while mass spectrometry confirms molecular identity. For each vial, the results are documented in one combined, batch-specific Certificate of Analysis report.

Protected in transit.

Every included product is freeze-dried to help preserve stability during storage and shipping. Rapid domestic fulfillment reduces unnecessary time and handling.

Lot history 8 released lots

Every batch released under each vial in this bundle, with the figure reported for each. Vials are shipped from current stock.

Compound	Lot	Reported	Purity	Net content	COA
Tesamorelin 10mg	TE-32025	2026-04-23	99.46%	10.00 mg	Pending
	T522	2026-04-23	99.58%	9.85 mg	PDF
	TE-33179	2026-04-08	99.83%	10.02 mg	Pending
	TE-32602	2026-03-19	99.58%	10.01 mg	Pending
Ipamorelin 10mg	IP341	2026-06-01	99.88%	10.29 mg	PDF
	IP-64086	2026-05-06	99.64%	10.03 mg	Pending
	IP-63509	2026-04-08	99.52%	10.02 mg	Pending
	IP-62932	2026-03-19	99.71%	10.01 mg	Pending

Frequently Asked Questions

What comes in the Tesamorelin 10mg + Ipamorelin 10mg bundle?

The bundle includes one Tesamorelin 10mg vial and one Ipamorelin 10mg vial. Each product arrives separately in lyophilized form with batch-specific COA documentation.

What research pathways are represented in this bundle?

The bundle spans GHRH-receptor and ghrelin-receptor signaling through two separate research materials. Each compound retains a distinct experimental profile, and the bundle does not establish clinical synergy.

Are these FDA-approved prescription products?

No. Some included active ingredients also appear in FDA-approved finished medicines, but the research vials in this bundle are not those approved products or substitutes. Every vial is supplied exclusively for controlled, non-clinical research.